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Summary
The dorsomedial hypothalamus (DMH) controls a number of
essential physiological responses. We have demonstrated that
the DMH plays an important role in the regulation of mammalian
aging and longevity. To further dissect the molecular basis of the
DMH function, we conducted microarray-based gene expression
profiling with total RNA from laser-microdissected hypothalamic
nuclei and tried to find the genes highly and selectively
expressed in the DMH. We found neuropeptide VF precursor
(Npvf), PR domain containing 13 (Prdm13), and SK1 family
transcriptional corepressor (Skor1) as DMH-enriched genes. Par-
ticularly, Prdm13, a member of the Prdm family of transcription
regulators, was specifically expressed in the compact region of
the DMH (DMC), where Nk2 homeobox 1 (Nkx2-1) is predomi-
nantly expressed. The expression of Prdm13 in the hypothalamus
increased under diet restriction, whereas it decreased during
aging. Prdm13 expression also showed diurnal oscillation and
was significantly upregulated in the DMH of long-lived BRASTO
mice. The transcriptional activity of the Prdm13 promoter was
upregulated by Nkx2-1, and knockdown of Nkx2-1 suppressed
Prdm13 expression in primary hypothalamic neurons. Interest-
ingly, DMH-specific Prdm13-knockdown mice showed signifi-
cantly reduced wake time during the dark period and decreased
sleep quality, which was defined by the quantity of electroen-
cephalogram delta activity during NREM sleep. DMH-specific
Prdm13-knockdown mice also exhibited progressive increases in
body weight and adiposity. Our findings indicate that Prdm13/
Nkx2-1-mediated signaling in the DMC declines with advanced
age, leading to decreased sleep quality and increased adiposity,
which mimic age-associated pathophysiology, and provides a
potential link to DMH-mediated aging and longevity control in
mammals.
Key words: aging; age-associated pathophysiology; Dorso-
medial hypothalamus; DMH-enriched gene; Nkx2-1; NREM
delta power; Prdm13.
Introduction
The hypothalamus is structurally divided into several functionally distinct
areas called nuclei, such as the arcuate, ventromedial, dorsomedial,
lateral, paraventricular, and suprachiasmatic nuclei of the hypothalamus
(Arc, VMH, DMH, LH, PVN, and SCN, respectively). Each hypothalamic
nucleus plays a crucial role in the regulation of various physiological
responses, including feeding behavior, metabolism, endocrine regula-
tion, physiological rhythm, emotion, and aging (Satoh & Imai, 2014).
Recent findings demonstrate that the hypothalamus functions as a high-
order ‘control center of aging,’ counteracting age-associated functional
changes and thereby promoting longevity in mammals (Satoh et al.,
2013; Zhang et al., 2013). Zhang et al. demonstrated that NF-jB
signaling in the mediobasal hypothalamus (MBH) is significantly
enhanced with advanced age, and suppressing NF-jB signaling in the
MBH retards aging and extends lifespan in mice (Zhang et al., 2013). We
also demonstrated that the mammalian NAD+-dependent protein
deacetylase Sirt1 in the hypothalamus, particularly the DMH and LH, is
critical to counteract age-associated declines in skeletal muscle mito-
chondrial function, physical activity, body temperature, oxygen con-
sumption, and sleep quality, and promote longevity in mice (Satoh et al.,
2013). Remarkably, increasing Sirt1 dosage only in the DMH is sufficient
to regain physical activity in aged mice to a similar level as in young mice
(Satoh et al., 2013). These results clearly demonstrate the importance of
the hypothalamus, more specifically DMH function, in controlling
mammalian aging.
Aging has a significant impact on DMH function. The DMH has been
known to regulate body temperature (Zaretskaia et al., 2003; Morrison
et al., 2008; Enriori et al., 2011), food-anticipating activity (Gooley
et al., 2006; Acosta-Galvan et al., 2011), autonomic stress responses
(Ulrich-Lai & Herman, 2009), food intake (Yang et al., 2009), and
reproduction (Kirby et al., 2009; Soga et al., 2014). Studies illustrate
several examples of the decline in DMH function with age. The capacity
of thermoregulation declines with age (Reynolds et al., 1985). In
humans, it has been reported that mean temperature declines with
age, after controlling for sex, body mass index, and white blood cell
count (Waalen & Buxbaum, 2011). Food-anticipating activity in response
to timed-restricted feeding also declines in old rats (Shibata et al., 1994).
The peripheral hormone ghrelin activates the DMH neurons, causing the
enhancement of food intake, and this enhancement by ghrelin declines
in old mice (Akimoto & Miyasaka, 2010). Finally, it has been reported
that the ability of the reproductive system declines with advanced age,
partly due to the reduction of DMH function (Soga et al., 2014). Given
those findings, it is clear that DMH function declines over age. Thus, it is
important to know the mechanisms by which the DMH controls these
functions to treat and/or prevent age-associated pathophysiology.
To dissect the molecular basis of DMH function, we decided to search
for the genes highly and selectively expressed in the DMH. Transcriptome
studies have so far shown that particular subsets of neuronal genes
exhibit clear spatial expression patterns across the adult mouse brain,
suggesting that these spatial expression patterns are related to the
unique physiological functions of distinct brain regions (Wang et al.,
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2010; Ko et al., 2013). Whereas other hypothalamic nuclei such as the
Arc, VMH, LH, and PVN have been well characterized for their genetic
and chemical identities (Elmquist et al., 1999; Leak & Moore, 2001;
Gottsch et al., 2004; Segal et al., 2005), efforts to characterize the DMH
have been very limited. Lee et al. (2012) reported a comprehensive gene
profile for the ventral subdivision of the DMH (DMV) where the leptin
receptor is exclusively expressed (Zhang et al., 2011). Although the
DMH-enriched genes identified in this study are only moderately
changed by dietary manipulations (Lee et al., 2012), subsequent studies
have proven the importance of these genes in response to leptin
(Bechtold et al., 2012). These findings indicate the potential for
exploring the DMH-enriched genes to further dissect the physiological
role of the DMH in neurobehavioral and metabolic regulation.
In this study, we identified several genes that display DMH-enriched
expression patterns by performing gene expression profiling with RNA
samples collected from laser-microdissected hypothalamic nuclei. We
examined the distribution of these candidate genes in the subcompart-
ments of the DMH and evaluated changes in gene expression under diet
restriction (DR), through the diurnal cycle, and with age. Among those
genes, we identified Prdm13, a member of the Prdm family (Fog et al.,
2012; Hohenauer & Moore, 2012), as a highly DMH-enriched gene. The
expression of Prdm13 increased under DR, whereas its expression
decreased with advanced age. Moreover, the expression level of Prdm13
in the DMH of long-lived brain-specific Sirt1-overexpressing transgenic
(BRASTO) mice is significantly higher than the level in wild-type control
mice. Interestingly, we found that mice with DMH-specific knockdown
of Prdm13 displayed a robust decline in sleep quality and a progressive
increase in body weight. These findings provide a novel possibility that a
specific subset of neurons, characterized by the expression of DMH-
enriched genes, regulate sleep homeostasis and metabolism and that the
functional deterioration of those specific DMH neurons could contribute
to age-associated pathophysiology in mammals.
Results
Identification of genes enriched in the Arc, VMH, DMH, and
LH
To identify genes selectively expressed in the DMH, we collected RNA
samples from four hypothalamic nuclei, namely the Arc, VMH, DMH,
and LH, using laser microdissection (Fig. S1) and conducted microarray
analysis to compare their gene expression profiles. We determined genes
selectively expressed greater than or equal to 10-fold in the Arc, VMH,
DMH, and LH, respectively, compared to the other hypothalamic nuclei
by calculating ratios of the signal intensities between each hypothalamic
nucleus. Using this criterion, 21, 15, four, and eleven genes were found
as genes enriched in the Arc, VMH, DMH, and LH, respectively (Fig. 1
and Table S1). We identified neuropeptide VF precursor (Npvf)
(NM_021892), gastrin-releasing peptide (Grp) (NM_175012), PR domain
containing 13 (Prdm13) (NM_001080771), and SK1 family transcrip-
tional corepressor (Skor1) (NM_172446) as the DMH-enriched genes
(Table 1). Our analysis also confirmed that agouti-related protein (Agrp)
(NM_007427), neuropeptide Y (Npy) (NM_023456), and kisspeptin 1
(Kiss1) (NM_178260) are exclusively expressed in the Arc, and nuclear
receptor subfamily 5, group A, member 1 (Nr5a1) (NM_139051) is
exclusively expressed in the VMH (Table S1). These genes are well-known
selective markers of the Arc and VMH (Elmquist et al., 1999; Gottsch
et al., 2004; Segal et al., 2005), providing further validation of our
results. Parvalbumin (Pvalb) (NM_013645) is among the top genes that
show much higher expression levels in the LH compared to the other
hypothalamic nuclei (Table S1), which was also confirmed by the Allen
Brain Atlas (]http://mouse.brain-map.org/), although Pvalb is also highly
expressed in other brain regions such as the cerebellum and cortex.
Expression patterns of Npvf, Prdm13, and Skor1 in the brain,
in the hypothalamus, and within the DMH
We next determined the anatomical distribution of these DMH-enriched
genes in the brain. Exploring DMH-enriched genes will have a potential
Fig. 1 Heat map representation of genes enriched in the Arc, VMH, DMH, and
LH. Genes expressed greater than or equal to 10-fold in each hypothalamic nucleus
compared to other hypothalamic nuclei by calculating ratios of signal intensities
between each hypothalamic nucleus are shown in the heat map. Microarray
analysis was conducted using two individual RNA samples from the Arc (Arc1 and
Arc2), VMH (VMH1 and VMH2), DMH (DMH1 and DMH2), and LH (LH1 and LH2).
Expression levels are indicated by the colored log2 scale of signal intensities shown
at the bottom of the figure. Probe ID from the Agilent Mouse_v1 8x60K array (left)
and corresponding symbol ID (right) are shown for each gene.
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to further address DMH function because the analysis of cell-type-
specific gene expression patterns could elucidate brain function (Wang
et al., 2010; Ko et al., 2013). We excluded Grp from the DMH-enriched
genes we identified because it is also highly expressed in other peripheral
tissues based on data available from the gene annotation portal BioGPS
(]http://biogps.org/#goto=welcome). We examined whether the expres-
sion of Npvf, Prdm13, and Skor1 was restricted to the hypothalamus.
qRT-PCR was conducted with total RNAs from the hypothalamus,
thalamus, hippocampus, cortex, and cerebellum. We found that Npvf
and Prdm13 were selectively localized in the hypothalamus, whereas
Skor1 was expressed in the hypothalamus, thalamus, hippocampus,
cortex, and most extensively in the cerebellum (Fig. 2A). We also
examined the expression profiles of these three genes through the
hypothalamic nuclei including the Arc, VMH, DMH, LH, PVN, and SCN.
Consistent with the data from our microarray analysis, Npvf, Prdm13,
and Skor1 were exclusively expressed in the DMH (Fig. 2B). The DMH is
further divided into three subdivisions: dorsal, compact, and ventral
DMH (DMD, DMC, and DMV, respectively) (Fig. S1A). The highest
expression of Npvf was observed in the DMV compared to the other two
DMH subdivisions, whereas the expression levels of Prdm13 and Skor1
were highest in the DMC (Fig. 2C).
Expression changes in Npvf, Prdm13, and Skor1 in the
hypothalamus under DR, through the 24-h diurnal cycle, and
with age
As our recent findings indicate the importance of the DMH in the
regulation of central adaptive responses to DR, physiological rhythms,
Table 1 Genes highly and selectively expressed in the DMH
Probe ID Acquisition number Arc1 Arc2 VMH1 VMH2 DMH1 DMH2 LH1 LH2
A_55_P1991310 NM_021892 75 82 369 92 4610 5816 427 25 Npvf
A_51_P356055 NM_175012 75 67 27 27 3242 5527 395 28 Grp
A_55_P2044897 NM_001080771 68 26 27 25 1942 2026 147 24 Prdm13
A_55_P2000434 NM_172446 27 25 60 87 1655 1425 170 56 Skor1
A_55_P2106504 NM_172446 25 23 26 24 1402 1363 193 25 Skor1




Fig. 2 Distribution of Npvf, Prdm13, and
Skor1 in the brain and specifically within
the hypothalamus. (A, B, and C) RNA
expression levels of Npvf, Prdm13, and
Skor1 were examined in various brain
regions including the hypothalamus,
thalamus, hippocampus, cortex, and
cerebellum (A), in the hypothalamic nuclei
including the Arc, VMH, DMH, LH, PVN,
and SCN (B) and in the DMH subdivisions
including the DMD, DMC, and DMV (C).
Expression levels were normalized to those
of the hypothalamus (A), DMH (B), or DMC
(C). Results are shown as mean  S.E.
(n = 2–3 mice for each group).
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and aging and longevity (Satoh et al., 2010, 2013), it is likely that these
DMH-enriched genes show interesting expression changes in these
conditions. To address this possibility, we first analyzed expression levels
of Npvf, Prdm13, and Skor1 in the hypothalamus under DR, an
experimentally proven dietary regimen that delays the aging process
and extends lifespan in a wide variety of organisms (Guarente, 2013).
The level of Npvf significantly decreased to about 40% under DR
compared to that of ad libitum (AL)-fed controls (Fig. 3A, left), whereas
levels of Prdm13 and Skor1 significantly increased about 50% and 45%,
respectively (Figs. 3B and C, left). We next examined the diurnal
expression patterns of Npvf, Prdm13, and Skor1. In the hypothalamus,
both Npvf and Prdm13 displayed statistically significant 24-h diurnal
cycles, with higher expression during the dark period and lower
expression during the light period (Figs. 3A and B, middle). The robust
oscillation was not observed in the expression of Skor1 in the
hypothalamus (Fig. 3C, middle). Lastly, we compared the expression of
Npvf, Prdm13, and Skor1 in the hypothalamus between mice at
4–6 months and 23–26 months of age. As the expression of Npvf and
Prdm13 increases during the dark period, we collected hypothalamic
samples from young and old mice during the dark period. The expression
levels of Npvf in the hypothalamus significantly decreased in mice at 23–
26 months of age, similar to its reduction under DR (Fig. 3A, right).
Intriguingly, the expression of Prdm13 significantly decreased with age,





Fig. 3 Alteration of Npvf, Prdm13, and
Skor1 expression levels under DR, through
the 24-h diurnal cycle, during the aging
process, and in aged BRASTO mice. RNA
expression levels of Npvf (A), Prdm13 (B),
and Skor1 (C) in the hypothalamus were
examined under ad libitum (AL)-fed versus
diet restriction (DR) conditions at Zeitgeber
time (ZT) 3 (left), every 4 h at different ZT
points (middle), and in young (4–6 months
of age) versus old (23–26 months of age)
mice at ZT15 (right). Expression levels were
normalized to those of AL (left) or young
(right) groups. (D) RNA expression levels of
Npvf, Prdm13, and Skor1 in the Arc, VMH,
DMH, and LH of BRASTO mice (Tg) and
wild-type mice (WT) at 20 months of age at
ZT15. Results are shown as mean  S.E.
(*P < 0.05, **P < 0.01, ***P < 0.001,
n = 4 mice each for AL and DR, n = 3–4
mice for each time point through 24 h,
n = 7–8 mice for each group young vs. old,
n = 4 mice each genotype). Shaded area
represents the dark period.
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of Skor1 was indistinguishable between young and old mice (Fig. 3C,
right). We also measured the expression levels of Npvf, Prdm13, and
Skor1 in hypothalamic nuclei (Arc, VMH, DMH, and LH) of aged BRASTO
mice, which showed significant delay in aging and lifespan extension
(Satoh et al., 2013). Interestingly, the levels of Prdm13 and Skor1 in the
DMH of aged BRASTO mice were significantly higher than the levels in
wild-type control mice, whereas the levels of Npvf in the DMH were
indistinguishable between genotypes (Fig. 3D). These results suggest a
possibility that Prdm13 and Skor1 contribute to the BRASTO phenotypes.
Given that the data from DR, 24-h diurnal cycle, aging, and aged
BRASTO mice, Prdm13 might be a key to counteract age-associated
functional declines and to promote lifespan in mammals (Satoh et al.,
2013).
The Nk2 homeobox 1 transcription factor Nkx2-1 shows DMC-
predominant expression in the DMH and upregulates Prdm13
transcription
Interestingly, as well as Prdm13, Nkx2-1, a substrate and binding partner
of Sirt1 in the DMH (Satoh et al., 2013), also displayed DMC-predom-
inant expression. Immunohistochemistry using a specific antibody
against Nkx2-1 revealed that Nkx2-1 is highly expressed in the DMC
compared to other hypothalamic nuclei (Fig. 4A). We also confirmed
that Nkx2-1 is colocalized with NeuN in the DMC (Figs. S2A–D). qRT-PCR
analysis clearly indicated that Nkx2-1 is most highly expressed in the
DMC among the DMH subdivisions (Fig. 4B). Given this anatomical
overlap between Prdm13 and Nkx2-1 and the diurnal oscillation of
Prdm13 expression, we hypothesized that Prdm13 could be a transcrip-
tional target of Nkx2-1, whose activity is regulated by Sirt1 in a diurnal
manner (Satoh et al., 2013). We found two predicted Nk2 binding sites
in the Prdm13 promoter region (Fig. 4C). To confirm whether the
Prdm13 promoter indeed responds to Nkx2-1, we generated a luciferase
reporter construct with the 360-bp genomic fragment of the Prdm13
promoter that contains these two Nk2 binding motif sequences.
Increasing Nkx2-1 expression significantly enhanced the transcriptional
activity of this Prdm13 promoter fragment in a dose-dependent manner
in HEK293 cells (Fig. 4D). Therefore, we next tested whether Nkx2-1 is
sufficient to promote Prdm13 expression in primary hypothalamic
neurons. Knocking down Nkx2-1 about 85–90% (data not shown)
significantly but moderately reduced Prdm13 expression in the hypo-
thalamic neurons (Fig. 4E). These results suggest that Prdm13 transcrip-
tion is regulated by Nkx2-1, although other factors or regulatory
mechanisms are involved in the transcriptional regulation of Prdm13.
Prdm13 in the DMH affects sleep quality and body weight
To further elucidate the physiological significance of Prdm13 in the




Fig. 4 Prdm13 as a downstream gene regulated by Nkx2-1. (A) Immunohistochemistry staining of Nkx2-1 in the hypothalamus. White dots represent staining with an anti-
Nkx2-1 antibody. We confirmed that these Nkx2-1-positive cells are NeuN-positive neurons (Fig. S2). (B) RNA expression levels of Nkx2-1 in the DMH subdivisions (DMD,
DMC, and DMV). Expression levels were normalized to those of DMC. Results are shown as mean  S.E. (n = 3 mice per subdivision). (C) Nucleotide sequence of the 360-bp
upstream region of the mouse Prdm13 gene. The transcription initiation site is defined as +1, and the start codon (ATG) is underlined. Predicted Nk2 family binding sites are
shown and underlined in pink color. (D) Luciferase activities driven by the 360-bp Prdm13 promoter fragment [Prdm13-Luc (360 bp)] in HEK293 cells cotransfected with
Nkx2-1 (pCMV-Nkx2-1). Luciferase activities in cells cotransfected with a backbone vector were normalized to 100%. Results are shown as mean values  S.E.
(***P < 0.001 by one-way ANOVA with Tukey–Kramer post hoc test, n = 9). (E) RNA expression levels of Prdm13 after knocking down Nkx2-1 in primary hypothalamic
neurons. Expression levels were normalized to those of firefly Luciferase (fLuc)-knockdown controls’ cells. Results are shown as mean values  S.E. (***P < 0.001 by
Student’s t-test, n = 7).
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stereotactic injection of lentiviruses carrying Prdm13 shRNA. We then
conducted electroencephalogram (EEG) recording on these mice. DMH-
specific Prdm13-knockdown mice and control shRNA-injected mice
showed indistinguishable sleep/wake architecture (Fig. 5A–C), except
that Prdm13-knockdown mice displayed a significantly lower amount
of wakefulness during the dark period compared to controls on both
Day 1 and Day 2 (Fig. 5A). This reduction of wakefulness in Prdm13-
knockdown mice was not accompanied by an alteration in the amount
of NREM sleep (Fig. 5B). We also found that the amount of REM sleep
was significantly higher in Prdm13-knockdown mice compared to
controls during the dark period only on Day 2 (Fig. 5C). It should be
noted that this statistically significant difference on Day 2 was
dependent on a single data point showing an abnormal peak at
ZT20 (shown as arrow in Fig. 5C). Additionally, this difference was not
observed on Day 1. These results suggest that Prdm13 in the DMH has
a minimal effect on the normal diurnal oscillation of sleep. On the
other hand, we found that the level of EEG delta power during NREM




(F) (G) (H) (I)
(E)
Fig. 5 Sleep–wake patterns, NREM delta
power, body weight, body composition,
and daily food intake in DMH-specific
Prdm13-knockdown mice. (A–C) The
amount of wakefulness (wake) (A), NREM
sleep (NREM) (B), and REM sleep (REM) (C)
in DMH-specific firefly Luciferase (fLuc)-
knockdown control mice and Prdm13-
knockdown mice. Numbers of bins are
shown as mean values  S.E. (*P < 0.05 by
Wilcoxon matched-pairs signed-rank test,
n = 5–6 mice per group). Shaded areas
represent the dark periods. A gray arrow in
C indicates the ZT20 time point on Day 2
when an abnormal peak was observed in
Prdm13-knockdown mice (see text). (D and
E) Electroencephalogram delta power in
NREM sleep (D) or in wake (E). Data are
shown as mean values  S.E. (*P < 0.05,
**P < 0.01 by Wilcoxon matched-pairs
signed-rank test, n = 5–6 mice per group).
(F–H) Body weight (F), fat mass (G), lean
mass (H), and daily food intake (I) for
Prdm13-knockdown mice are normalized
to the average values of fLuc-knockdown
control mice within each cohort (3 cohorts).
Fat mass and lean mass were measured by
EchoMRI. Individual data are plotted, and
mean values and S.E. are shown
(*P < 0.05, **P < 0.01 by Student’s t-test,
n = 6 mice per group).
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reduced in DMH-specific Prdm13-knockdown mice compared to
control mice during both light and dark periods (Fig. 5D), whereas
these differences were not observed during the wake time (Fig. 5E).
This delta power defect caused by Prdm13 knockdown is very similar to
that caused by Nkx2-1 knockdown (Satoh et al., 2013). Thus, these
results indicate that Prdm13 in the DMH, as well as its upstream
regulator Nkx2-1 (Satoh et al., 2013), significantly affects the level of
sleep depth or quality in mice.
Poor sleep quality contributes to excessive weight gain, and better
sleep quality confers protection against obesity (Mavanji et al., 2010).
Therefore, we measured body weight in DMH-specific Prdm13-knock-
down and control mice 2.5 months after stereotactic surgery. Because
actual measured values of body weight, fat mass, and lean mass in
control and Prdm13-knockdown mice fluctuated between cohorts, we
calculated the percent changes compared to control mice in each
individual cohort. The relative values of body weight and fat mass in
Prdm13-knockdown mice were significantly higher than those in control
mice (Fig. 5F and G), whereas relative values of lean mass did not differ
between control and Prdm13-knockdown mice (Fig. 5H). We also
observed that the amounts of daily food intake were indistinguishable
between these two groups, suggesting that the increases in body weight
and fat mass in Prdm13-knockdown mice are not due to increased daily
food intake. These results indicate that DMH-specific Prdm13-knock-
down mice exhibit progressive gain of adipose tissue when their sleep
quality is affected.
Discussion
In our present study, we identified three DMH-enriched genes, Npvf,
Prdm13, and Skor1, from microarray analysis using laser-microdissected
hypothalamic nuclei. Intriguingly, Prdm13 is enriched in the DMC, where
Sirt1 and Nkx2-1 are highly colocalized (Satoh et al., 2013). Indeed, the
transcriptional activity of the Prdm13 promoter is upregulated by Nkx2-
1, and the knockdown of Nkx2-1 decreases Prdm13 expression in
primary hypothalamic neurons. Interestingly, the expression of Prdm13
increases under DR, whereas its expression declines with age. In
addition, the expression level of Prdm13 in the DMH of aged BRASTO
mice is significantly higher than the level in wild-type control mice.
Furthermore, DMH-specific Prdm13-knockdown mice display reduced
sleep quality and increased body weight, phenotypes very similar to old
animals (Ancoli-Israel, 2009; Kuk et al., 2009). Given that Sirt1 and
Nkx2-1 function together in the hypothalamus to counteract age-
associated functional declines (Satoh et al., 2013), Prdm13 might also
play an important role as one of their key target genes in the DMH to
mediate age-associated pathophysiology, particularly sleep quality and
body weight.
Different from other hypothalamic nuclei, it has been challenging to
identify selective marker genes for the DMH. Lee et al. previously
reported Gpr50, Pcsk5, Sulf1, Grp, and Rorb as genes highly expressed in
the DMV (Lee et al., 2012). Our microarray analysis did not identify those
genes, except for Grp, which is highly expressed in other peripheral
tissues. This is likely due to differences in sample collection between the
two studies: DMV in their study versus DMH in our study. In fact, Prdm13
and Skor1 are highly expressed in the DMC, but not in the DMV. Npvf
could have been detected in their study because Npvf is highly expressed
in the DMV based on our results. Kasukawa et al. also reported Npvf as a
potential candidate maker for the DMH, based on the BrainStars
database that they created (]http://brainstars.org/) (Kasukawa et al.,
2011). Additionally, the localization of Npvf in the DMV can be
confirmed in the Allen Brain Atlas (]http://mouse.brain-map.org/). Taken
together, Npvf and Prdm13 are specifically expressed in the DMV and
DMC, respectively, potentially providing good selective markers for the
DMH.
The physiological role of Prdm13 during adulthood is still poorly
understood. Prdm13 belongs to the Prdm family of zinc finger
transcriptional regulators (Fog et al., 2012; Hohenauer & Moore,
2012). Recently, it has been reported that Prdm13 has histone
methyltransferase activity (Hanotel et al., 2014). During development,
Prdm13 is directly downstream of Ptf1a, a basic helix–loop–helix
transcription activator and is required for the specification of GABAergic
and glutamatergic neurons (Chang et al., 2013). Remarkably, we
demonstrated that Prdm13 in the DMH is important to maintain sleep
quality and body weight associated with adiposity. DMH-specific
Prdm13-knockdown mice displayed decreased wakefulness during the
dark period and robust decline in NREM delta power through the entire
diurnal cycle compared to those in control mice. They also displayed
progressively increased body weight with adiposity. Because sleep quality
and metabolism are highly associated (Morselli et al., 2012), poor sleep
quality by knockdown of Prdm13 in the DMH might cause increased
body weight secondarily. Alternatively, weight gain with adiposity might
be regulated by the same set of DMH neurons but through an
independent mechanism (see below). Sleep quality is regulated by
circadian rhythmicity and sleep–wake homeostasis. Provided that NREM
delta power is regulated independently of sleep duration (Davis et al.,
2011), the observed abnormality of sleep in DMH-specific Prdm13-
knockdown mice might be due to defects in sleep–wake homeostasis.
The DMH has been suggested to be a relay point for signals going from
the SCN to the locus coeruleus (Aston-Jones et al., 2001), the main site
for synthesizing norepinephrine in the brain and facilitating arousal and
sleep–wake homeostasis. Thus, it will be interesting to examine whether
DMH-specific Prdm13-knockdown mice also display defects in sleep
homeostasis.
It is likely that the Nkx2-1/Prdm13 pathway in the DMH has a
significant contribution to the Sirt1-mediated control of aging and
longevity (Fig. 6). At the molecular level, Nkx2-1 is deacetylated by Sirt1
in the hypothalamus during the dark period when Sirt1 is activated
(Satoh et al., 2013). In addition, Sirt1 cooperates with Nkx2-1 to
upregulate Ox2r transcription (Satoh et al., 2013). Whether Sirt1 is also
involved in the regulation of Prdm13 transcription and whether age-
associated reduction of Prdm13 expression in the hypothalamus is due to
a decline in Sirt1 activity still need to be investigated. It will also be
important to examine potential roles of downstream targets of Prdm13,
Nkx2-1, and Sirt1 in the DMH in the pathogenesis of age-associated
sleep abnormality and metabolic complications. We demonstrated that
BRASTO mice display delays in age-associated physiological declines and
lifespan extension (Satoh et al., 2013). Maintaining quality of sleep is
one of the striking phenotypes in aged BRASTO mice. In contrast, DMH/
LH-specific Nkx2-1- or Sirt1-knockdown mice (Satoh et al., 2013) and
DMH-specific Prdm13-knockdown mice display lower NREM delta power
compared to controls. In addition, Sirt1 and Nkx2-1 are colocalized in the
DMC, and Prdm13 is also localized in the same region. These results
strongly imply that Prdm13, Nkx2-1, and Sirt1 together in the DMC play
an important role in the regulation of sleep quality during the aging
process. On the other hand, the role of DMH neurons expressing Nkx2-1
and/or Prdm13 in the regulation of body weight and adiposity is still
unclear. Although DMH-specific Prdm13-knockdown mice display pro-
gressive weight gain, DMH/LH-specific Nkx2-1-knockdown mice do not
display such phenotypes (unpublished finding). Much longer observation
time or excessive energy intake might be necessary to produce definitive
changes in body weight in DMH-specific Nkx2-1-knockdown mice.
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Alternatively, this phenotypic difference between Nkx2-1- and Prdm13-
knockdown mice might be due to the heterogeneity of DMH neurons,
particularly DMC neurons, expressing Nkx2-1, Prdm13, and/or Sirt1. In
other words, Prdm13 in distinct subpopulations of DMC neurons, each
of which are characterized by different neuropeptides or neurotrans-
mitters, might differentially regulate sleep quality and body weight.
These distinct neuronal subsets could mediate different functions
through different projections but together contribute to the prevention
against age-associated physiological decline and the promotion of
longevity in mammals.
In conclusion, our microarray-based gene expression profiling for
hypothalamic nuclei provided valuable marker genes for the DMH.
Investigation of the physiological roles of DMH-enriched genes in sleep
homeostasis and metabolism will shed new light on the understanding
of aging and longevity control in mammals.
Experimental procedures
Animal study
C57BL/6J female mice were purchased from the Jackson Laboratory (Bar
Harbor, ME, USA). All mice were maintained under 12-h light/12-h dark
conditions and had free access to food and water. For DR, mice were fed
60% of control for 3 months as previously described (Satoh et al.,
2010). The procedure for stereotactic delivery of lentiviruses was
described previously (Satoh et al., 2013). Body composition was mea-
sured using EchoMRITM 3-in-1 Body Composition Analyzer (EchoMRI LLC,
Houston, TX, USA). BRASTO females in C57BL/6J background were
described previously (Satoh et al., 2010). All animal procedures were
approved by the Washington University Animal Studies Committee and
were in accordance with NIH guidelines.
Sleep analysis
Briefly, isoflurane-anesthetized mice were surgically implanted with
screw electrodes in the skull for electroencephalogram (EEG) and
platinum wire electrodes in the nuchal muscle for electromyogram
(EMG) recording. After a minimum of 2-week recovery, we conducted
EEG/EMG recording under each physiological condition. The 10-s epochs
of EEG/EMG signals were scored by visual examination as wake, lower
amplitude delta (1–4 Hz) and theta (4–8 Hz) frequency with higher and
variable amplitude EMG activity; NREM sleep, predominantly higher
amplitude delta activity and low amplitude EMG activity; or REM sleep,
predominantly low amplitude rhythmic theta activity and very low
amplitude EMG activity. The 10-s EEG epochs then were processed by
Fourier transformation to calculate the percentage of delta power
relative to total power in the 0.1–25 Hz frequency range for each 10-s
epoch. A Wilcoxon matched-pairs signed-rank test was used to compare
differences of hourly data points through the light and dark periods
between groups in sleep analysis.
Sample collection of hypothalamic nuclei
The Arc, VMH, DMH, LH, PVN, and SCN were dissected from two
C57BL/6J females at 3 months of age by laser microdissection using the
Leica LMD 6000 system (Leica Microsystems, Buffalo Grove, IL, USA). We
confirmed that there was no contamination from surrounding hypotha-
lamic nuclei by conducting quantitative real-time RT-PCR using probes
Agrp, Nr5a1, hypocretin (Hcrt), and corticotropin-releasing hormone
(Crh) (Fig. S1B). RNA was isolated from each hypothalamic nucleus using
the Arcturus PicoPure RNA Isolation Kit (Life Technologies, Grand Island,
NY, USA). The detailed procedure was described previously (Satoh et al.,
2010). For microarray, the quality of total RNA was determined by
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA),
and two samples for each hypothalamic nucleus were used for
microarray analysis. For quantitative real-time RT-PCR, RNA concentra-
tion was determined by NanoDrop, and cDNA was synthesized using the
Applied Biosystems High-Capacity cDNA Reverse Transcription Kit (Life
Technologies, Grand Island, NY, USA).
Agilent one color microarray and expression analysis
Total RNA was amplified by the WTA2 kit (Sigma-Aldrich, St. Louis, MO,
USA), according to the manufacturer’s protocol. cDNAs were chemically
labeled with Kreatech ULS RNA Labeling Kit (Kreatech Diagnostics,
Durham, NC, USA). Labeled cDNA was purified with Qiagen PCR
purification columns, and cDNAs were quantitated on a NanoDrop
spectrophotometer. cDNA samples were hybridized to Agilent Mou-
se_v1 8x60K microarrays (Design ID-028005, Agilent Technologies,
Santa Clara, CA, USA). Slides were scanned on an Agilent C-class
Microarray scanner to detect Cy5 fluorescence, according to the
manufacturer’s specifications. Gridding and analysis of images was
performed using Feature Extraction software (v11.5.1.1, Agilent Tech-
nologies, Santa Clara, CA, USA). To identify differentially expressed
genes in each hypothalamic nucleus, ratios of signal intensities to each
hypothalamic nucleus were calculated, and genes whose expression
levels were greater than or equal to 10-fold in each hypothalamic
nucleus compared to the others were selected. The heat map for each
log2-transformed gene expression level was generated using Partek
Fig. 6 Model for the compact region of the DMH (DMC) in controlling sleep
quality and metabolism during aging. The levels of Prdm13 decline with age in the
DMC, causing altered expression of downstream target genes. This age-associated
dysfunction of DMC neurons likely reduces sleep quality and causes metabolic
complications such as increased adiposity during the aging process. Prdm13
transcription is upregulated by Nkx2-1, whose activity is regulated by Sirt1-
mediated deacetylation. Therefore, the age-associated decline in Prdm13
expression might be due to the reduction of Sirt1 activity during the aging process.
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Genomics Suite (Partek Inc., St. Louis, MO, USA). The microarray data
were deposited into the NCBI GEO database (GEO Accession Number
GSE58238).
Quantitative real-time RT-PCR
Total RNA was extracted from brain regions using the Ambion PureLink
RNA Mini Kit (Life Technologies, Grand Island, NY, USA). Hypothalamic
nuclei were collected by laser microdissection as described above. RNA
was reverse-transcribed into cDNA as described above, and quantitative
real-time RT-PCR was conducted as described in detail previously (Satoh
et al., 2013). Relative expression levels of the genes of interest were
normalized to Gapdh levels.
Luciferase assay
HEK293 cells were transfected with a firefly luciferase reporter driven by
360-bp Prdm13 promoter, pCMV-Nkx2-1 (a gift from Dr. Shioko Kimura,
National Cancer Institute, Bethesda, MD, USA) or control vector, and a
Renilla luciferase expression vector. Luciferase assays were conducted as
described previously (Satoh et al., 2010). Firefly luciferase activity levels
were normalized to Renilla luciferase activity of each sample.
Primary hypothalamic neuronal isolation and Nkx2-1
knockdown
Hypothalami were dissected from E15.5 C57BL/6J mice, and hypotha-
lamic neurons were isolated as described previously (Satoh et al., 2013).
Hypothalamic neurons were plated at 2.5 9 105 cells/well in 6-well
plates coated with 100 lg ml-1 poly-L-lysine, and cells were maintained
in Neurobasal media containing 10% FBS, 1 9 B27, 2 mM L-glutamine,
and penicillin/streptomycin. Cultures were treated with 10 lM Ara-C
(Sigma-Aldrich, St. Louis, MO, USA) after 2 days in vitro (DIV). Media
was replaced to Dulbecco’s modified Eagle’s media containing 50% F12,
5 mM HEPES, 1x B27, 1x N2, 0.5% L-glutamax, 0.5 mM sodium
pyruvate, and penicillin/streptomycin after 4 DIV. On the next day, Nkx2-
1 shRNA lentivirus was added, and cells were harvested after 7 DIV. RNA
was isolated as described previously (Satoh et al., 2013).
Statistical analysis
Statistical analyses were carried out using unpaired or paired Student’s t-
tests for two groups and one-way ANOVA with the Tukey–Kramer post
hoc test for more than two groups. The rhythmicity of gene expression
was assessed by the JTK-Cycle (Hughes et al., 2010), which is available
as a computationally efficient R script (]http://openwetware.org/wiki/
HughesLab:JTK_Cycle). In all analyses, we set the a level at 0.05. We
used Microsoft Excel 2008 and SPSS 11.0 to conduct statistical analyses.
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